Relative persistence of AAV serotype 1 vector genomes in dystrophic muscle

Genetic Vaccines and Therapy

Volumn 6, Issue , 2008, Pages

  Pacak, Christina A ^a,b   Conlon, Thomas ^a,b   Mah, Cathryn S ^a,b   Byrne, Barry J ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SARCOGLYCAN; BETA GALACTOSIDASE; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DUPLICATION; GENE EXPRESSION; GENE LOSS; GENE NUMBER; GENOME ANALYSIS; HINDLIMB; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCULAR DYSTROPHY; NEWBORN; NONHUMAN; NONVIRAL GENE THERAPY; REPORTER GENE; SEROTYPE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ADENO-ASSOCIATED VIRUS - 1; MUS;

EID: 54949105845     PISSN: None     EISSN: 14790556     Source Type: Journal    
DOI: 10.1186/1479-0556-6-14     Document Type: Article

References (11)

1. Moore SA Shilling CJ Westra S Wall C Wicklund MP Stolle C Brown CA Michele DE Piccolo F Winder TL Limb-girdle muscular dystrophy in the United States J Neuropathol Exp Neurol 2006, 65:995-1003 10.1097/ 01.jnen.0000235854.77716.6c 17021404
2. Kang PBKL Chapter 216: The Muscular Dystrophies The Online Metabolic and Molecular Bases of Inherited Disease McGraw-Hill Scriver CRBA, Valle D, Sly WS 8 2007
3. Eymard B Romero NB Leturcq F Piccolo F Carrie A Jeanpierre M Collin H Deburgrave N Azibi K Chaouch M Primary adhalinopathy (alpha-sarcoglycanopathy): Clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy Neurology 1997, 48:1227-1234 9153448
4. Pacak CA Walter GA Gaidosh G Bryant N Lewis MA Germain S Mah CS Campbell KP Byrne BJ Long-term Skeletal Muscle Protection After Gene Transfer in a Mouse Model of LGMD-2D Mol Ther 2007, 15:1775-1781 10.1038/ sj.mt.6300246 17653106
5. Fougerousse F Bartoli M Poupiot J Arandel L Durand M Guerchet N Gicquel E Danos O Richard I Phenotypic Correction of alpha-Sarcoglycan Deficiency by Intra-arterial Injection of a Muscle-specific Serotype 1 rAAV Vector Mol Ther 2007, 15:53-61 10.1038/sj.mt.6300022 17164775
6. Kessler PD Podsakoff GM Chen X McQuiston SA Colosi PC Matelis LA Kurtzman GJ Byrne BJ Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein Proc Natl Acad Sci USA 1996, 93:14082-14087 19498 8943064 10.1073/ pnas.93.24.14082
7. Schnepp BC Clark KR Klemanski DL Pacak CA Johnson PR Genetic fate of recombinant adeno-associated virus vector genomes in muscle J Virol 2003, 77:3495-3504 149530 12610125 10.1128/JVI.77.6.3495-3504.2003
8. Pacak CA Mah CS Thattaliyath BD Conlon TJ Lewis MA Cloutier DE Zolotukhin I Tarantal AF Byrne BJ Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo Circ Res 2006, 99:e3-9 10.1161/01.RES.0000237661.18885.f6 16873720
9. Warren GL Ingalls CP Armstrong RB Temperature dependency of force loss and Ca(2+) homeostasis in mouse EDL muscle after eccentric contractions Am J Physiol Regul Integr Comp Physiol 2002, 282:R1122-1132 11893617
10. Arruda VR Stedman HH Nichols TC Haskins ME Nicholson M Herzog RW Couto LB High KA Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model Blood 2005, 105:3458-3464 1895010 15479726 10.1182/ blood-2004-07-2908
11. Salic A Mitchison TJ A chemical method for fast and sensitive detection of DNA synthesis in vivo Proc Natl Acad Sci USA 2008, 105:2415-2420 2268151 18272492 10.1073/pnas.0712168105